Bladder

Phase II Trial of Neoadjuvant Cisplatin, Gemcitabine and Sunitinib Malate Followed by Radical Cystectomy for Transitional Cell Carcinoma (TCC) of the Bladder

A Pilot Study of Neoadjuvant Dasatinib Followed by Radical Cystectomy for Transitional Cell Carcinoma of the Bladder

A Phase II Trial of Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell Cancer: Hoosier Oncology Group GU04-75

A Phase II Study of ALIMTA in Patients With Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium

Weekly Paclitaxel and Gemcitabine in Advanced Transitional Cell Carcinoma of the Urothelium: A Phase II Hoosier Oncology Group Study